[HTML][HTML] A multicenter observational study of incretin-based drugs and heart failure
…, M Dahl, CR Dormuth, KK Clemens… - … England Journal of …, 2016 - Mass Medical Soc
Background There is concern that antidiabetic incretin-based drugs, including dipeptidyl
peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) analogues, can increase …
peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) analogues, can increase …
Sex disparities in cardiovascular outcome trials of populations with diabetes: a systematic review and meta-analysis
KK Clemens, M Woodward, B Neal, B Zinman - Diabetes Care, 2020 - Am Diabetes Assoc
BACKGROUND Sex differences have been described in diabetes cardiovascular outcome
trials (CVOTs). PURPOSE We systematically reviewed for baseline sex differences in …
trials (CVOTs). PURPOSE We systematically reviewed for baseline sex differences in …
Testing, infection and complication rates of COVID-19 among people with a recent history of homelessness in Ontario, Canada: a retrospective cohort study
Background: People with a recent history of homelessness are believed to be at high risk of
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and, when …
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and, when …
Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study
Objective To determine whether the use of incretin based drugs compared with sulfonylureas
is associated with an increased risk of incident pancreatic cancer in people with type 2 …
is associated with an increased risk of incident pancreatic cancer in people with type 2 …
Association between incretin-based drugs and the risk of acute pancreatitis
…, M Dahl, CR Dormuth, KK Clemens… - JAMA internal …, 2016 - jamanetwork.com
Importance The association between incretin-based drugs, such as dipeptidyl peptidase 4 (DPP-4)
inhibitors and glucagon-like peptide 1 (GLP-1) agonists, and acute pancreatitis is …
inhibitors and glucagon-like peptide 1 (GLP-1) agonists, and acute pancreatitis is …
[HTML][HTML] Trends in antihyperglycemic medication prescriptions and hypoglycemia in older adults: 2002-2013
Background Over the last decade, several new antihyperglycemic medications have been
introduced including those associated with a lower hypoglycemia risk. We aimed to …
introduced including those associated with a lower hypoglycemia risk. We aimed to …
Fracture risk of sodium-glucose cotransporter-2 inhibitors in chronic kidney disease
…, AX Garg, K Naylor, MA Weir, KK Clemens - Clinical Journal of the …, 2022 - journals.lww.com
Results After weighting, we identified a total of 38,994 new users of a SGLT2 inhibitor and
37,449 new users of a DPP-4 inhibitor and observed a total of 342 fractures at 180 days and …
37,449 new users of a DPP-4 inhibitor and observed a total of 342 fractures at 180 days and …
[HTML][HTML] High temperatures and cardiovascular-related morbidity: a scoping review
KR Cicci, A Maltby, KK Clemens… - International journal of …, 2022 - mdpi.com
The primary objective of this review was to synthesize studies assessing the relationships
between high temperatures and cardiovascular disease (CVD)-related hospital encounters (ie, …
between high temperatures and cardiovascular disease (CVD)-related hospital encounters (ie, …
The hypoglycemic risk of glyburide (glibenclamide) compared with modified-release gliclazide
Objectives The risk for hypoglycemia when taking glyburide compared with modified-release
gliclazide remains to be established in older adults in routine care. We investigated the risk …
gliclazide remains to be established in older adults in routine care. We investigated the risk …
Use of sodium–glucose cotransporter-2 inhibitors and risk of acute kidney injury in older adults with diabetes: a population-based cohort study
C Iskander, DZ Cherney, KK Clemens, SN Dixon… - Cmaj, 2020 - Can Med Assoc
BACKGROUND: Regulatory agencies warn about the risk of acute kidney injury (AKI) after
the initiation of sodium-glucose cotransporter-2 (SGLT2) inhibitors. Our objective was to …
the initiation of sodium-glucose cotransporter-2 (SGLT2) inhibitors. Our objective was to …